Endoscopic Submucosal Dissection Market size was valued at USD 372.68 million in 2024 and is expected to reach USD 738.35 million by 2037, registering around 5.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of endoscopic submucosal dissection is assessed at USD 388.78 million. The primary growth driver for the market is the relentless evolution of technology within endoscopy procedures. The continuous refinement of tools and imaging capabilities in the field of ESD not only enhances the precision of diagnostic procedures but also significantly improves the efficacy of therapeutic interventions.
Furthermore, advancements in electrosurgical tools, incorporating features like tissue-specific energy delivery and enhanced cutting capabilities, contribute to the procedural efficiency and safety of ESD. These innovations empower healthcare professionals to perform intricate dissections with reduced collateral damage to surrounding tissues, thereby optimizing patient outcomes. According to a recent report, the U.S. was the biggest exporter of medical technology devices in the world.
Additionally, ESD is a minimally invasive technique used for the removal of early-stage gastrointestinal tumors, particularly in the esophagus, stomach, and colorectal region.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.4% |
|
Base Year Market Size (2024) |
USD 372.68 million |
|
Forecast Year Market Size (2037) |
USD 738.35 million |
|
Regional Scope |
|
Product (Gastroscopes & Colonoscopes, Knives, Injection Agents)
The gastroscopes & colonoscopes segment in the endoscopic submucosal dissection market is estimated to gain a revenue share of 60% in the year 2037. The segment growth can be attributed to the ongoing advancements in colonoscopic techniques, including improved maneuverability and visualization capabilities, which contribute to the success rates of ESD procedures. With the aging global population, there is a corresponding increase in the prevalence of colorectal diseases.
Colonoscopes have become indispensable tools in addressing the higher incidence of colorectal cancer and other gastrointestinal conditions in the elderly population. The age-related rise in colorectal diseases contributes to the sustained growth of the colonoscope segment within the ESD market. They are integral to the detection and treatment of colorectal cancer through ESD procedures. The alarming rise in colorectal cancer incidence worldwide underscores the crucial role of colonoscopes in early diagnosis and intervention. The American Cancer Society reported over 147,000 new cases of colorectal cancer in the United States in 2020.
End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers)
The hospital segment in the endoscopic submucosal dissection market is expected to garner a significant share in the year 2037 due to the increasing awareness among patients regarding minimally invasive treatment options that fuels the demand for ESD procedures. In addition, hospitals, as primary healthcare providers, witness a surge in patients seeking advanced, less invasive alternatives. To meet this demand, hospitals invest in the necessary infrastructure, training, and technology, positioning themselves at the forefront of ESD adoption and growth.
Furthermore, government initiatives and healthcare policies play a pivotal role in shaping the healthcare landscape, including the adoption of advanced medical procedures like ESD. Various supportive policies and funding initiatives encourage hospitals to invest in infrastructure and training for ESD procedures. As governments prioritize the improvement of healthcare services, hospitals become key beneficiaries, driving growth in the hospitals segment. The hospital, as hubs for medical innovation and advancement, are quick to adopt cutting-edge technologies.
Our in-depth analysis of the global market includes the following segments:
|
Product |
|
|
End User |
|
|
Indication |
|
APAC Market Forecast
The endoscopic submucosal dissection market in the Asia Pacific region is projected to hold the largest revenue share of 47% by the end of 2037. The Asia Pacific region, particularly countries like Japan, China, and South Korea, experiences a disproportionately high burden of gastric cancer. Moreover, the prevalence of this disease creates a substantial market for ESD procedures, which are increasingly recognized as effective interventions for early-stage gastric cancer. The pressing need to address the high incidence of gastric cancer serves as a primary growth driver for the ESD market in the Asia Pacific region. According to a recent report, Asia accounts for nearly 50% of the global incidence of gastric cancer.
The region is at the forefront of adopting cutting-edge endoscopic technologies. The ongoing advancements, including high-definition imaging and real-time monitoring, enhance the precision and success rates of ESD procedures. This commitment to technological progress positions the region as a hub for innovation in endoscopy, driving growth in the ESD market.
North American Market Statistics
The endoscopic submucosal dissection market in the North American region is projected to hold the second-largest share during the forecast period. Colorectal cancer is a significant health concern in North America, particularly in the United States. The high incidence of colorectal cancer creates a substantial demand for effective treatment methods such as ESD. As a result, healthcare providers in North America are increasingly adopting ESD procedures as an essential tool in the fight against colorectal cancer.
North America is at the forefront of integrating cutting-edge technologies into healthcare practices. Continuous advancements in endoscopic imaging technologies, including high-definition scopes and advanced software, enhance the precision of ESD procedures. This commitment to technological innovation positions North America as a hub for advanced endoscopic techniques, driving growth in the ESD market.
The prevalence of GERD in North America contributes to a higher incidence of Barrett's esophagus and other gastrointestinal conditions. ESD procedures are increasingly recognized as effective interventions for treating early-stage lesions associated with GERD. As a result, the demand for ESD in North America is fueled by the need to address GERD-related complications.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?